Leitlinie
Treatable Traits in Bronchiectasis: A Precision Medicine Framework Aligned with the 2025 ERS Clinical Practice Guidelines
Current Pulmonology Reports · 18.07.2026 · 15 (1)
DOI: 10.1007/s13665-026-00415-5 ↗Kurz gefasst
Leitlinie in der Zeitschrift Current Pulmonology Reports, online erschienen am 18.07.2026. Verfasst von Akhil P. Sawant. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sawant, A. P. (2026). Treatable Traits in Bronchiectasis: A Precision Medicine Framework Aligned with the 2025 ERS Clinical Practice Guidelines. Current Pulmonology Reports, 15(1). https://doi.org/10.1007/s13665-026-00415-5
Vancouver
Sawant AP. Treatable Traits in Bronchiectasis: A Precision Medicine Framework Aligned with the 2025 ERS Clinical Practice Guidelines. Current Pulmonology Reports. 2026;15(1). doi:10.1007/s13665-026-00415-5
BibTeX
@article{Sawant2026,
author = {Sawant, Akhil P.},
title = {Treatable Traits in Bronchiectasis: A Precision Medicine Framework Aligned with the 2025 ERS Clinical Practice Guidelines},
journal = {Current Pulmonology Reports},
year = {2026},
volume = {15},
number = {1},
doi = {10.1007/s13665-026-00415-5}
}
EUVIMED